September 02, 2021 Signatera, a “tumor-informed” blood test developed by Natera, can detect circulating tumor DNA in the bloodstream for certain types of cancers. “What makes the tumor DNA different is that it has certain mutations that actually lead to the uncontrolled cell growth that became the cancer,” Solomon Moshkevich, the General Manager of Oncology … Read more
August 31, 2021 Published in Nature Communications and part-funded by the NIHR Maudsley Biomedical Research Centre, the research determined a set of age-related cut-off levels of NfL which could inform its potential use in primary care settings through a simple blood test. Joint Senior Author on the study, Dr Abdul Hye from the NIHR Maudsley … Read more
August 26, 2021 Targeted treatment for cancer, such as immunotherapy, blocks the abnormal growth of cancerous cells by attacking specific molecules which instruct them to grow and spread. However, to evaluate its effectiveness, clinicians often have to rely on imaging techniques such as MRI and CT scans, which are costly, and can only be determined … Read more
August 24, 2021 The novel odor-based test relies on a machine-learning algorithm to identify unique combinations of volatile organic compounds, or VOCs, in the vapors wafting from blood plasma samples. In the lab, the technology was able to detect and identify elusive cancer cells with 95 percent accuracy. Researchers were scheduled to detail the technology’s … Read more
This percentage was even higher — 50% — among Generation Z and millennials, according to the data. Older adults also expressed interest in telehealth services, with 48% of respondents aged 65 years and older reporting that they will likely continue to use telehealth after the COVID-19 pandemic. The data are from a series of surveys … Read more
August 18, 2021 The device, nicknamed the “living pharmacy,” is aiming to control the body’s circadian clock, reducing the time it takes to recover from disruptions to sleep cycles by half. The wireless device could have applications in military and hospital usage, helping military personnel and first responders working shifting schedules better recover from sleep … Read more
August 13, 2021 Uncontrolled gestational diabetes mellitus (GDM) management has been associated with poor neonatal outcomes such as increased birth weight, macrosomia, and neonatal hypoglycemia. Fetal size is used to guide the management of gestational diabetes. However, aggressive glucose control may lead to small-for-gestational-age (SGA) infants, placing them at an increased risk for adverse outcomes; … Read more
August 10, 2021 The consequences can be dire. Preterm birth is the leading cause of infant death, and surviving preemies can develop short and long-term complications including those affecting the lungs, heart, and brain. However, Mira Moufarrej says it does not have to be that way. T he 26-year-old Stanford bioengineering graduate student developed simple … Read more
August 06, 2021 Dive Insight: The concept of an SBOM has been under discussion for years within the federal government. FDA in 2018 issued a Medical Device Safety Action Plan noting the agency was considering requiring firms to develop SBOMs as part of premarket submissions and make them available to customers and users “so that … Read more
August 03, 2021 The medtech industry is broadly supportive of Medicare Coverage of Innovative Technology (MCIT), which will mean breakthrough medical devices automatically get Medicare reimbursement on the day they receive FDA clearance or approval. AdvaMed CEO Scott Whitaker said the policy is “good government” and “good common sense,” arguing it is logical to facilitate … Read more